ReviewFrontiers in immunology2026

Rewiring the immune response in lung cancer: current progress in bispecific antibodies, CAR-T therapy, and the rise of

Lei He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.